CA2369892A1 - Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same - Google Patents

Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same Download PDF

Info

Publication number
CA2369892A1
CA2369892A1 CA002369892A CA2369892A CA2369892A1 CA 2369892 A1 CA2369892 A1 CA 2369892A1 CA 002369892 A CA002369892 A CA 002369892A CA 2369892 A CA2369892 A CA 2369892A CA 2369892 A1 CA2369892 A1 CA 2369892A1
Authority
CA
Canada
Prior art keywords
tgf
beta
receptor
antibody
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002369892A
Other languages
English (en)
French (fr)
Inventor
Hoon Shin
Chang Gi Lim
Seung Won Jin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2369892A1 publication Critical patent/CA2369892A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/495—Transforming growth factor [TGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA002369892A 1999-04-09 2000-04-10 Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same Abandoned CA2369892A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR1999/12568 1999-04-09
KR19990012568 1999-04-09
KR19990043935 1999-10-12
KR1999/43935 1999-10-12
PCT/KR2000/000329 WO2000062062A1 (en) 1999-04-09 2000-04-10 METHOD FOR QUANTIFYING TRANSFORMING GROWTH FACTOR-β1 AND METHOD FOR DETECTING CANCER BY USING SAME

Publications (1)

Publication Number Publication Date
CA2369892A1 true CA2369892A1 (en) 2000-10-19

Family

ID=26634921

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002369892A Abandoned CA2369892A1 (en) 1999-04-09 2000-04-10 Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same

Country Status (11)

Country Link
EP (1) EP1166112A4 (id)
JP (1) JP2002541479A (id)
CN (1) CN1355882A (id)
AU (1) AU768029B2 (id)
BR (1) BR0009607A (id)
CA (1) CA2369892A1 (id)
ID (1) ID30316A (id)
MX (1) MXPA01009942A (id)
NZ (1) NZ514596A (id)
TR (1) TR200102917T2 (id)
WO (1) WO2000062062A1 (id)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2430257A1 (en) * 2000-11-28 2002-06-06 Amgen, Inc. Transforming growth factor-beta-related molecules and uses thereof
JP4834835B2 (ja) * 2006-07-27 2011-12-14 国立大学法人浜松医科大学 自閉症の診断薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59195162A (ja) * 1983-04-21 1984-11-06 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の検定用試薬
JPS59216058A (ja) * 1983-05-23 1984-12-06 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の定量法
JPS59226864A (ja) * 1983-06-07 1984-12-20 Toyo Jozo Co Ltd トランスホ−ミンググロスファクタ−の酵素免疫測定法
JPS6018764A (ja) * 1983-07-12 1985-01-30 Toyo Jozo Co Ltd トランスホ−ミンググロスフアクタ−の免疫測定法
JPH02126157A (ja) * 1988-11-04 1990-05-15 Tosoh Corp ヒトトランスフォーミンググロースファクターβの免疫学的測定方法
WO1993010215A1 (en) * 1991-11-15 1993-05-27 Memorial Sloan-Kettering Cancer Center Purified proteoglycan betaglycan, compositions, and methods
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods

Also Published As

Publication number Publication date
MXPA01009942A (es) 2003-07-14
EP1166112A1 (en) 2002-01-02
WO2000062062A1 (en) 2000-10-19
BR0009607A (pt) 2002-01-08
NZ514596A (en) 2003-03-28
EP1166112A4 (en) 2004-11-10
AU768029B2 (en) 2003-11-27
JP2002541479A (ja) 2002-12-03
ID30316A (id) 2001-11-22
CN1355882A (zh) 2002-06-26
TR200102917T2 (tr) 2002-03-21
AU4147100A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
US9823251B2 (en) Anti-Uroplakin II antibodies systems and methods
KR101282811B1 (ko) 가스트린 방출 펩티드 전구체에 대한 항체 및 그 용도
CA2519105A1 (en) Monoclonal antibody and hybridoma producing the same
EP0550561B1 (en) Purification of cytokeratin fragments
US20010046686A1 (en) Sensitive detection of wild-type and mutant EGFR by specific ELISA assays in any biological sample
KR102029394B1 (ko) 치쿤구니아 바이러스 감염 진단용 단일클론항체, 이를 생산하는 하이브리도마 및 이를 이용한 치쿤구니아 바이러스 감염 진단 방법
CA2369892A1 (en) Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same
CN113480646B (zh) 特异性结合h1.4移码突变蛋白的单克隆抗体制备及其应用
JP2001122900A (ja) 抗−ＤＮａｓｅγ抗体並びにその製造及び使用
JP3920556B2 (ja) 短縮型ミッドカイン（ｔＭＫ）タンパク質特異的モノクローナル抗体及びその用途
JP2008515871A (ja) 新規ガン関連抗体及び抗原並びにガンの診断におけるそれらの使用
KR100378746B1 (ko) 체액내 활성 세포증식억제인자-베타1의 정량 방법 및 이를이용한 암 검사 방법
JP2925479B2 (ja) 肺小細胞癌検出薬及びその使用
US5786451A (en) 23 Kd human retinal CAR antigen
CN109776679B (zh) 一种丝氨酸蛋白酶抑制因子spink1的抗体、其制备方法和应用
CN111349170B (zh) 免疫相关gtp酶家族m（irgm）的单克隆抗体及其应用
JP4829961B2 (ja) プロスタシン部分ペプチド及び抗プロスタシン抗体
WO2006057623A1 (en) Runx3 antibodies and method of obtaining the antibodies
WO2012077643A1 (ja) ｃｏｆｉｌｉｎ１タンパク質の免疫学的測定方法
JP3107248B2 (ja) 抗体および免疫化学的測定法
JPH06125784A (ja) モノクローナル抗体，ハイブリドーマ，その製造法および用途
KR20040085749A (ko) 레지스틴에 대한 단클론 항체, 이의 제조 방법, 및 용도
JP2006271390A (ja) 短縮型ミッドカイン（ｔＭＫ）タンパク質特異的モノクローナル抗体の製造方法
WO2006121047A1 (ja) 生体試料中メグシンの測定方法
JP2011160696A (ja) 修飾ヒトｉｇｆ−１／ｅペプチドに対する抗体

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued